Английская Википедия:FUB-144

Материал из Онлайн справочника
Версия от 04:14, 6 марта 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|Chemical compound}} {{Drugbox | IUPAC_name = [1-(4-Fluorobenzyl)-1''H''-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | image = FUB-144_structure.png <!--Clinical data--> | tradename = | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = <!-- A / B / C / D / X --> | pregnancy_category = | legal_AU = <!-- Unscheduled / S2 / S...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

FUB-144 (also known as FUB-UR-144) is an indole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is an analogue of UR-144 and XLR-11 where the pentyl chain has been replaced with fluorobenzyl.

Legal status

In the United States, FUB-144 was temporarily emergency scheduled by the DEA in 2019.[2] and made a permanent Schedule I Controlled Substance on April 7, 2022.[3]

Sweden's public health agency suggested classifying FUB-144 as hazardous substance on March 24, 2015.[4]

See also

References

Шаблон:Reflist

Шаблон:Cannabinoids